Lance Armstrong ordered to testify about doping

Lance Armstrong ordered to testify about doping

DOPING:Disgraced cyclist Lance Armstrong has been ordered to testify under oath about his use of performance-enhancing drugs. Photo: Associated Press

AUSTIN, Texas (AP) — Lance Armstrong has been ordered to give sworn videotaped testimony next month about using performance-enhancing drugs to win the Tour de France seven times.

Armstrong has been sued by a Texas company seeking the return of about $12 million in performance bonuses. An arbitration panel has issued subpoenas for testimony from Armstrong on June 12 and his longtime business manager Bill Stapleton on June 9.

The cyclist has asked the Texas Supreme Court to intervene. He says a previous settlement with SCA Promotions is binding and cannot be reopened.

Armstrong’s attorneys noted the subpoenas in a request for the Supreme Court to rule quickly.

Armstrong provided written sworn testimony last year in an unrelated lawsuit, and for the first time provided names of those he says assisted in his doping.

Recent Headlines

in Sports

Tigers still No. 1, Oklahoma up to third


The 12-0 Tigers picked up 53 of the 61 first-place votes after holding off South Carolina.

in National

Congress returns to looming deadlines on budget, highways


Lawmakers are returning to Capitol Hill for a two- to three-week sprint to wrap up work on the budget, highway funding and taxes.

in Sports

Broncos spoil Patriots’ perfect record with OT win


Recognizing the run play that was called likely would go nowhere against the New England Patriots' defensive alignment, Denver Broncos quarterback Brock Osweiler audibled to a different one. The result was electric.

in Sports

Kobe Bryant retiring


Los Angeles Lakers great Kobe Bryant, arguably the best player of his generation, announced on Sunday he will retire after the 2015-16 National Basketball Association season.

in Sports

Monday’s Sports Minute


Here's a look at some of the big sports headlines making news today, Monday, Nov. 30.